Fund Holdings — Velan Capital Investment Management LP

Total Portfolio Value:
$184.95M
Total Bought:
$71.38M
Total Sold:
$31.39M
Net Transaction:
+$39.99M
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Alimera Sciences Inc13,608,53313,608,5330$58.79M$53.07M28.70%-$5.72M
Jasper Therapeutics, Inc.(JSPR)01,471,904+1,471,904$0$42.10M22.76%+$42.10M
Praxis Precision Medicines, Inc.(PRAX)345,666350,666+5,000$7.70M$21.40M11.57%+$13.70M
Heron Therapeutics, Inc.(HRTX)6,986,7446,986,7440$11.88M$19.35M10.46%+$7.48M
Adma Biologics Inc2,136,1001,528,601-607,499$9.66M$10.09M5.45%+$433.6K
Tourmaline Bio Inc319,080319,0800$8.35M$7.31M3.95%-$1.05M
Outlook Therapeutics, Inc.(OTLK)0500,000+500,000$0$5.97M3.23%+$5.97M
Optinose Inc3,796,8613,001,191-795,670$4.90M$4.38M2.37%-$516.2K
TELA Bio, Inc.(TELA)77,500746,087+668,587$513.0K$4.23M2.29%+$3.72M
Inspire Medical Systems, Inc.(INSP)18,00018,0000$3.66M$3.87M2.09%+$204.5K
Aquestive Therapeutics Inc0600,000+600,000$0$2.56M1.38%+$2.56M
Elevation Oncology Inc497,299497,2990$267.1K$2.55M1.38%+$2.28M
InspireMD, Inc.(NSPR)904,029904,0290$2.54M$2.14M1.16%-$397.7K
Geron Corporation(GERN)778,500500,000-278,500$1.64M$1.65M0.89%+$7.4K
Milestone Pharmaceuticals Inc.(MIST)0650,000+650,000$0$1.16M0.63%+$1.16M
Rezolute, Inc.(RZLT)0400,000+400,000$0$1.02M0.55%+$1.02M
enVVeno Medical Corporation(NVNO)172,235172,2350$885.3K$937.0K0.51%+$51.7K
Kiora Pharmaceuticals Inc01,100,000+1,100,000$0$776.6K0.42%+$776.6K
Aslan Pharmaceuticals LtdADS0625,000+625,000$0$384.5K0.21%+$384.5K
Aclaris Therapeutics, Inc.(ACRS)1,761,5950-1,761,595$1.85M$0—-$1.85M
Apellis Pharmaceuticals Inc
COM
50,0000-50,000$2.99M$0—-$2.99M
Immunogen Inc189,5000-189,500$5.62M$0—-$5.62M
Immunovant, Inc.(IMVT)27,5000-27,500$1.16M$0—-$1.16M
Jasper Therapeutics, Inc.(JSPR)11,219,0360-11,219,036$8.55M$0—-$8.55M
Lantheus Holdings, Inc.(LNTH)75,0000-75,000$4.65M$0—-$4.65M
Roivant Sciences Ltd.SHS(ROIV)500,0000-500,000$5.62M$0—-$5.62M
Page 1 of 1
Velan Capital Investment Management LP — 13F Holdings — Q1 2024 | TickerTrail